CERO(Delisted)
CERo TherapeuticsยทNASDAQ
--
--(--)
CERO fundamentals
CERo Therapeutics (CERO) released its earnings on Aug 22, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -61.71 (YoY -41040.00%), missed estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-61.71
-41040.00%
Report date
Aug 22, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
CERo Therapeutics (CERO) key financial stats and ratios, covering profitability, financial health, and leverage.
CERo Therapeutics (CERO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
CERo Therapeutics (CERO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
CERo Therapeutics (CERO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does CERo Therapeutics (CERO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track CERo Therapeutics (CERO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
